Copyright
©The Author(s) 2025.
World J Clin Oncol. Feb 24, 2025; 16(2): 97107
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.97107
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.97107
Table 1 Demographic and clinical factor recorded
Demographic | Clinical |
Age | Smoking |
Sex | Ethanol |
Working status | Number of medications |
Family history of CRC | |
Personal history of CRC | |
Years since diagnosis |
Table 2 Clinical and demographic characteristics of cohort
n (%) | |
Sex | |
Male | 15 (29.41) |
Female | 36 (70.59) |
Age at SPS diagnosis (years), mean | 48.14 |
SD | 10.88 |
Range | 23-62 |
Family history of CRC | |
1st degree | 15 (29.41) |
2nd degree | 9 (17.65) |
No | 23 (45.10) |
Unknown | 2 (3.92) |
Missing data | 2 (3.92) |
Previous history of CRC | |
CRC prior to Dx of SPS | 1 (1.96) |
CRC at time of SPS Dx | 0 (0) |
CRC post SPS Dx | 0 (0) |
No CRC | 48 (94.12) |
Missing data | 2 (3.92) |
Smoking status | |
Yes | 4 (7.84) |
No | 36 (70.59) |
Ex-smoker | 9 (17.65) |
Missing data | 2 (3.92) |
Ethanol intake (> 30 gm per day) | |
Yes | 7 (13.73) |
No | 42 (82.35) |
Missing data | 2 (3.92) |
Employment status | |
Full-time | 33 (64.71) |
Part-time | 12 (23.53) |
Casual | 4 (7.84) |
Not working | 2 (3.92) |
Table 3 Health anxiety score distribution
Mean (SD), range | |
Total sample | 13.43 (6.16), 2-30 |
Sex | |
Male | 13.87 (5.55), 7-25 |
Female | 13.25 (6.46), 2-30 |
Age | |
< 45 years | 12.17 (8.04), 5-30 |
≥ 45 years | 13.82 (5.12), 2-25 |
Health anxiety (%) | |
Score ≥ 18 | n = 11 (21.57) |
Score ≥ 30 | n = 1 (1.96) |
Table 4 Attitudes towards personalised surveillance of serrated polyposis syndrome patients, with or without health anxiety
Health anxiety | No health anxiety | P value | 95%CI | Odds ratio | |
Personalised surveillance | 0.0019091 | 2.42-34.19 | 7.60 | ||
Not worried | 2 | 30 | |||
Slightly worried | 6 | 9 | |||
Worried | 3 | 1 | |||
Very worried | 0 | 0 |
- Citation: Thompson A, Dierick NR, Heiniger L, Kostalas SN. Health anxiety and work loss in patients diagnosed with serrated polyposis syndrome: A cross sectional study. World J Clin Oncol 2025; 16(2): 97107
- URL: https://www.wjgnet.com/2218-4333/full/v16/i2/97107.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i2.97107